Russian Chemical Reviews
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive
Impact factor
Guidelines for authors

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS



Usp. Khim.:
Year:
Volume:
Issue:
Page:
Find






Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register


Russian Chemical Reviews, 2021, Volume 90, Issue 11, Pages 1454–1491
DOI: https://doi.org/10.1070/RCR5013
(Mi rcr4369)
 

This article is cited in 16 scientific papers (total in 16 papers)

Synthesis and biological activity of aza and deaza analogues of purine nucleosides

E. S. Matyugina, S. N. Kochetkov, A. L. Khandazhinskaya

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
English full-text Citations (16)
Abstract: Analogues and derivatives of nucleic acid components have been used as key drugs in different areas of medicine over the past decades. The replacement of one or more nitrogen atoms of the heterocyclic base with a CH group affords deazapurine nucleoside analogues, and the replacement of the methine group with a nitrogen atom gives azapurine derivatives. A combination of aza and deaza moieties in the purine base leads to aza(deaza)-modified bases. Some nucleoside analogues were found to exhibit pronounced anticancer and antiviral activity. The synthesis and evaluation of biological activity of aza- and deazapurine nucleoside analogues have attracted interest from researchers four decades ago. This review describes and integrates the studies concerning certain aspects of the synthesis and(or) activity of various representatives of this class of compounds. The structure–biological activity relationships are analyzed. The successful approaches to the design of aza- and deazapurine nucleoside analogues are considered. A comparison is given for the methods of chemical and enzymatic synthesis of these compounds.
The bibliography includes 161 references.
Keywords: aza/deaza purine nucleosides, heterocyclic base, carbohydrate fragment, biological activity.
Funding agency Grant number
Russian Science Foundation 19-74-10048
Received: 04.12.2020
Russian version:
Uspekhi Khimii, 2021, Volume 90, Issue 11, Pages 1454–1491
DOI: https://doi.org/10.1070/RCR5013
Bibliographic databases:
Document Type: Article
Language: English
Original paper language: Russian
Citation: E. S. Matyugina, S. N. Kochetkov, A. L. Khandazhinskaya, “Synthesis and biological activity of aza and deaza analogues of purine nucleosides”, Usp. Khim., 90:11 (2021), 1454–1491; Russian Chem. Reviews, 90:11 (2021), 1454–1491
Citation in format AMSBIB
\Bibitem{MatKocKha21}
\by E.~S.~Matyugina, S.~N.~Kochetkov, A.~L.~Khandazhinskaya
\paper Synthesis and biological activity of aza and deaza analogues of purine nucleosides
\jour Usp. Khim.
\yr 2021
\vol 90
\issue 11
\pages 1454--1491
\mathnet{http://mi.mathnet.ru/rcr4369}
\crossref{https://doi.org/10.1070/RCR5013}
\adsnasa{https://adsabs.harvard.edu/cgi-bin/bib_query?2021RuCRv..90.1454M}
\elib{https://elibrary.ru/item.asp?id=47508079}
\transl
\jour Russian Chem. Reviews
\yr 2021
\vol 90
\issue 11
\pages 1454--1491
\crossref{https://doi.org/10.1070/RCR5013}
\isi{https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=000731636300004}
\scopus{https://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85114220953}
Linking options:
  • https://www.mathnet.ru/eng/rcr4369
  • https://doi.org/10.1070/RCR5013
  • https://www.mathnet.ru/eng/rcr/v90/i11/p1454
  • This publication is cited in the following 16 articles:
    Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    Uspekhi Khimii Uspekhi Khimii
    Statistics & downloads:
    Abstract page:96
     
      Contact us:
     Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2024